Selected article for: "current study and inflammatory response"

Author: Fedele, Debora; De Francesco, Antonella; Riso, Sergio; Collo, Alessandro
Title: Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview
  • Cord-id: 5plfhpef
  • Document date: 2020_9_8
  • ID: 5plfhpef
    Snippet: The world is currently facing the coronavirus disease (COVID-19) pandemic which places great pressure on health care systems and workers, often presents with severe clinical features, and sometimes requires admission into intensive care units. Derangements in nutritional status, both for obesity and malnutrition, are relevant for the clinical outcome in acute illness. Systemic inflammation, immune system impairment, sarcopenia, and preexisting associated conditions, such as respiratory, cardiova
    Document: The world is currently facing the coronavirus disease (COVID-19) pandemic which places great pressure on health care systems and workers, often presents with severe clinical features, and sometimes requires admission into intensive care units. Derangements in nutritional status, both for obesity and malnutrition, are relevant for the clinical outcome in acute illness. Systemic inflammation, immune system impairment, sarcopenia, and preexisting associated conditions, such as respiratory, cardiovascular, and metabolic diseases related to obesity, could act as crucial factors linking nutritional status and the course and outcome of COVID-19. Nevertheless, vitamins and trace elements play an essential role in modulating immune response and inflammatory status. Overall, evaluation of the patient's nutritional status is not negligible for its implications on susceptibility, course, severity, and responsiveness to therapies, in order to perform a tailored nutritional intervention as an integral part of the treatment of patients with COVID-19. The aim of this study was to review the current data on the relevance of nutritional status, including trace elements and vitamin status, in influencing the course and outcome of the disease 3 mo after the World Health Organization's declaration of COVID-19 as a pandemic.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acute lung injury: 1, 2, 3, 4
    • ace inhibitor and acute onset: 1
    • ace inhibitor and acute phase: 1
    • ace inhibitor and acute risk: 1, 2, 3, 4, 5
    • ace inhibitor and adaptive innate: 1
    • ace inhibitor and adipose tissue: 1
    • ace inhibitor and admission rate: 1
    • ace inhibitor and lung damage: 1
    • ace inhibitor and lung disease: 1
    • ace inhibitor and lung infection: 1
    • ace inhibitor and lung injury: 1, 2, 3, 4
    • adaptive innate and adjuvant therapy: 1, 2
    • adaptive innate and liver expression: 1, 2
    • adaptive innate and liver injury: 1, 2, 3
    • adaptive innate and low grade inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • adaptive innate and low production: 1
    • adaptive innate and low serum level: 1
    • adaptive innate and low vitamin: 1, 2, 3, 4
    • adaptive innate and lung development: 1, 2, 3, 4, 5, 6